Vitamin Blue (VTMB) Annual Income Statement

Annual · GAAP · USD millions
Access VTMB quarterly income statements →
Quarterly income statement trends provide context on Vitamin Blue's margins, operating leverage, and earnings trajectory.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2012)
2012
Revenues
Total Revenue0.13
Costs & Expenses
Cost of Goods and Services Sold0.07
Gross Profit0.06
Selling, Administration, Marketing0.17
Other Operating Expense / -Income0.00
Total operating costs including COS0.25
Operating income / -loss-0.12
Interest Expense, Debt-0.10
Net Interest (-)Expense / Income-0.10
Extinguishment of Debt0.02
Other loss / -income-0.12
Total costs & expenses0.24
Income & Taxes
Income / -loss before income taxes-0.11
Income after income taxes-0.11
Income / -loss from continuing operations-0.11
Net income / -loss-0.11
Income / -loss to shareholder-0.11
EBIT-0.01
EBITD-0.01
EBITDA-0.01
Earnings Per Share
Basic EPS (excl. extra items)0.00
Basic Net EPS0.00
Basic shares outstanding (Mill. of Units)540.49
Diluted Net EPS0.00
Diluted average shares (Mill. of Units)540.49
4 historic quarters locked

Sign in to unlock the full Vitamin Blue income statement history.

About VTMB Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.